Clinical Trial Update: Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates that alpha-lipoic acid reduces left ventricular mass in normotensive patients with type 2 diabetes mellitus and corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Wuhan General Hospital of Guangzhou Military Command | Conditions: Type 2 Diabetes, Coronary Artery Disease | Phase 4 | Status: COMPLETED